Trafalgar International TRFA
OTC TRFA
$0.75 +0.00 (+0.00%)
At close: Nov 6, 2026 · 4:00 PM EST

Trafalgar International (TRFA) EBITDA Margin (2020 - 2021)

Updated

Trafalgar International (TRFA) recorded EBITDA Margin of -548.63% in FY2021, down 2059.18 percentage points from 1510.55% in FY2020.

Analysis

Trafalgar International (TRFA) EBITDA Margin (2020 - 2021) Analysis & Trends

  • Per Business Quant data, TRFA's EBITDA Margin was 1510.55% in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 54.65%
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 32.68%
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 46.88%
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 40.75%
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 46.62%
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 50.63%
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 42.49%
10 Trafalgar International 708,701.25 658,380.25 - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 59.12%
Jun 30, 2020 653.87%
API Access

Trafalgar International EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TRFA&period=max&api_key=YOUR_API_KEY